SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027709
Filing Date
2016-11-04
Accepted
2016-11-04 17:17:01
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2016 10_Q 09302016 vsar-10q_20160930.htm 10-Q 1386334
2 EX-10.1 TEIJIN EXCLUSIVE LICENSE & SUPPLY AGREEMENT vsar-ex101_420.htm EX-10.1 649274
3 EX-31.1 vsar-ex311_7.htm EX-31.1 16713
4 EX-31.2 vsar-ex312_8.htm EX-31.2 16427
5 EX-32.1 vsar-ex321_9.htm EX-32.1 5128
  Complete submission text file 0001564590-16-027709.txt   4995737

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vsar-20160930.xml EX-101.INS 861462
7 XBRL TAXONOMY EXTENSION SCHEMA vsar-20160930.xsd EX-101.SCH 33115
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20160930_cal.xml EX-101.CAL 27683
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20160930_def.xml EX-101.DEF 83573
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20160930_lab.xml EX-101.LAB 234625
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20160930_pre.xml EX-101.PRE 175794
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 161975994
SIC: 2834 Pharmaceutical Preparations